Autoantibodies in ANCA-associated Vasculitis

Rheumatic Disease Clinics of North America

Volumn 36, Issue 3, 2010, Pages 479-489

  Wiik, Allan S ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

ANCA; Autoantibodies; Necrotizing vasculitis; Pathophysiology

Indexed keywords

AUTOANTIBODY; AZUROCIDIN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G; LACTOFERRIN; LEUKOCYTE ELASTASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; LYSOZYME; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NEUTROPHIL DERIVED FACTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NEUTROPHIL SPECIFIC AUTOANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ANCA ASSOCIATED FOCAL NECROTIZING GLOMERULONEPHRITIS; ANCA ASSOCIATED VASCULITIS; ANTIBODY SCREENING; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; IMMUNOPATHOGENESIS; NECROTIZING ARTERITIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RHEUMATOID ARTHRITIS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; ENDOTHELIUM, VASCULAR; HUMANS; MYELOBLASTIN; PEROXIDASE;

EID: 77955261286     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.05.001     Document Type: Review

References (59)

1. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994, 37(2):187-192.
2. Wiik A. Antineutrophil cytoplasm antibodies (ANCAs) and strategy for diagnosing ANCA-associated vasculitides. Manual of molecular and clinical laboratory immunology 2006, 1053-1058. ASM Press, Washington, DC. B. Detrick, R.G. Hamilton, J.D. Folds (Eds.).
3. Wiik A. Autoantibodies in vasculitis. Vasculitis 2008, 53-65. Oxford University Press, Oxford (UK). 2nd edition. G. Hall, L. Bridges (Eds.).
4. Brons R.H., Bakker H.I., van Wijk R.T., et al. Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?. Clin Exp Immunol 2000, 119(3):566-573.
5. Pendergraft W.F., Preston G.A., Shah R.R., et al. Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004, 10(1):72-79.
6. Salama A.D., Pusey C.D. Shining a LAMP on pauci-immune focal segmental glomerulonephritis. Kidney Int 2009, 76(1):15-17.
7. Jennette J.C., Falk R.N. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990, 15(6):517-529.
8. Kallenberg C.G.M., Brouwer E., Mulder E., et al. ANCA - pathophysiology revisited. Clin Exp Immunol 1995, 100(1):1-3.
9. Calabresi P., Edwards E.A., Schilling R.F. Fluorescent anti-globulin studies in leukopenic and related disorders. J Clin Invest 1959, 38:2091-2100.
10. Calabresi P., Thayer W.R., Spiro H.M. Demonstration of circulating antinuclear globulins in ulcerative colitis. J Clin Invest 1961, 40:2126-2133.
11. Wiik A. Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy 1980, 35(4):263-289.
12. Wiik A. Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases. Autoimmun Rev 2002, 1(1-2):67-72.
13. Wiik A., Brimnes J., Heegaard N. Distinct differences in autoantigen specificity of antineutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases. Isr Med Assoc J 1999, 1(1):4-7.
14. van der Woude F.J., Rasmussen N., Lobatto S., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985, 1(8426):425-429.
15. Wiik A., van der Woude F.J. The new ACPA/ANCA nomenclature. Neth J Med 1990, 36(3-4):107-109.
16. Wiik A.S. Anti-neutrophil cytoplasmic antibodies in primary small vessel vasculitides. Scand J Rheumatol 1996, 25(2):65-69.
17. Davies D., Moran M.E., Niall J.F., et al. Segmental glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology. Br Med J 1982, 285(6342):606.
18. Goldschmeding R., van der Schoot C.E., Ten Bokkel Huininck D., et al. Wegener's granulomatosis autoantibodies identify a novel diiso-fluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989, 84(5):1577-1587.
19. Niles J.L., McCluskey R.T., Ahmad M.E., et al. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989, 74(6):1888-1893.
20. Gupta S.K., Niles J.L., McCluskey R.T., et al. Identity of Wegener's autoantigen (p29) with proteinase and myeloblastin. Blood 1990, 76(10):2162.
21. Falk R.J., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318(25):1651-1657.
22. Bini P., Gabay J.E., Teitel A. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol 1992, 149(4):1409-1415.
23. Williams R.C., Staud R., Malone C.C., et al. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. J Immunol 1994, 152(9):4722-4737.
24. Griffith M.E., Coulthart S., Pemberton A., et al. Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site. Clin Exp Immunol 2001, 123(1):170-177.
25. Fujinaga M., Chernaia M., Halenbeck R., et al. The crystal structure of PR 3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J Mol Biol 1996, 261(2):267-278.
26. Müller-Bérat N., Minowada J., Tsuji-Takayama K., et al. The phylogeny of proteinase 3/myeloblastin, the autoantigen in Wegener's granulomatosis, and myeloperoxidase as shown by immunohistochemical studies on human leukemic cell lines. Clin Immunol Immunopathol 1994, 70(1):51-59.
27. Sturrock A.B., Franklin K.F., Rao G., et al. Structure, chromosomal assignment, and expression of the gene for proteinase 3, the Wegener's granulomatosis autoantigen. J Biol Chem 1992, 267(29):21193-21199.
28. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 1989, 320(6):365-376.
29. Zeng J., Fenna R.E. X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. J Mol Biol 1992, 226(1):185-207.
30. Chang K.S., Schroeder W., Siciliano M.J. The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemia. Leukemia 1987, 1(5):458-462.
31. Falk R.J., Becker R., Terrell R., et al. Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol 1992, 89(2):274-278.
32. Wiik A. Drug-induced vasculitis. Curr Opin Rheumatol 2008, 20(1):35-39.
33. Kain R., Matsui K., Exner M., et al. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granules and a related membrane protein in glomerular endothelial cells. J Exp Med 1995, 181(2):585-597.
34. Kain R., Exner M., Brandes R., et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008, 10(10):1088-1096.
35. Bonaci-Nikolic B., Nikolic M.M., Andrejevic S., et al. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005, 7(5):R1072-R1081.
36. Wiik A. Clinical use of serological tests for ANCA: what do the studies say?. Rheum Dis Clin North Am 2001, 27(4):799-813.
37. Wiik A. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes. Mod Rheumatol 2009, 19(6):590-599.
38. Hagen E.C., Daha M., Hermans J., et al. The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis. Kidney Int 1998, 53(3):743-753.
39. Fritzler M.J., Wiik A., Fritzler M.L., et al. The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 2003, 5(4):192-201.
40. Jayne D. The diagnosis of vasculitis. Best Pract Res Clin Rheumatol 2009, 23(3):445-453.
41. Boomsma M.M., Stegeman C.A., van der Leij M.J., et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000, 43(9):2025-2033.
42. Segelmark M., Phillips B.D., Hogan S.L., et al. Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis. Clin Diagn Lab Immunol 2003, 10(5):769-774.
43. Terrier B., Saadoun D., Séne D., et al. Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides. Ann Rheum Dis 2009, 68(19):1564-1571.
44. Birck R., Schmidt W.H., Kaelsch I.A., et al. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis 2006, 47(1):15-23.
45. Franssen C., Gans R., Kallenberg C., et al. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 1998, 244(3):209-216.
46. Wang F., Chen M., Zhao M.H. Neutrophil degranulation in antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis. J Nephrol 2009, 22(4):491-496.
47. Eisenberger U., Fakhouri F., Vanhille P., et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant 2005, 29(7):1392-1399.
48. Meroni P.L., Del Papa N., Raschi E., et al. Antiendothelial cell antibodies (AECA): from laboratory curiosity to another useful autoantibody. The decade of autoimmunity 1999, 285-294. Elsevier Science, Amsterdam. Y. Shoenfeld (Ed.).
49. Holmen C., Christensson M., Liu J., et al. Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies. Kidney Int 2004, 66(3):1049-1060.
50. Yu F., Zhao M.H., Zhang Y., et al. Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity. Clin Exp Immunol 2005, 139(3):569-574.
51. Chanseaud Y., Pena-Lefebvre P.G., Guilpain P., et al. IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin Immunol 2003, 109(2):165-178.
52. Del Papa N., Guidali L., Sironi M., et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996, 39(5):758-766.
53. Chan T.M., Frampton G., Jayne D.R.W., et al. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies. Am J Kidney Dis 1993, 22(3):387-392.
54. Gunnarsson A., Hellmark T., Wieslander J. Molecular properties of the Goodpasture epitope. Biol Chem 2000, 275(40):30844-30848.
55. Rutgers A., Heeringa P., Damoiseaux J.G., et al. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Intern Med 2003, 14(5):287-295.
56. Lionaki S., Jennette J.C., Falk R.J. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol 2007, 29(4):459-474.
57. Levy J.B., Hammad T., Coulthart A., et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004, 66(4):1535-1540.
58. Vecchi M.L., Radice A., Renda F., et al. Anti-laminin autoantibodies in ANCA-associated vasculitis. Nephrol Dial Transplant 2000, 15(10):1600-1603.
59. Rees J.D., Lanca S., Marques P.V., et al. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis 2006, 65(1):109-111.